The effect of remimazolam and propofol on visual evoked potential

The effect of remimazolam and propofol on visual evoked potential: a non-inferiority trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1011230057

Enrollment

Registered

2024-01-22

Start date

2024-01-22

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain neoplasm Brain tumor

Interventions

General anesthesia is performed using remimaozolam infusion.

C522201

intravenous anesthesia

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo neurosurgery using VEP monitoring Patients whose age more than 20 yrs

Exclusion criteria

Exclusion criteria: Patients who VEP monitoring can not be performed appropriately

Design outcomes

Primary

Measure	Time frame
Amplitude of visual evoked potential at Oz between N1-P1	—

Secondary

Measure	Time frame
Amplitude of visual evoked potential at Oz between P1-N2 Latency of visual evoked potential at N1, P1 and N2 Hemodynamic state including blood pressure and heart rate Depth of sedation evaluated by bistral index value	—

Contacts

Public ContactTomohiro Chaki

Sapporo Medical University School of Medicine Hospital

chakitomohiro0728@yahoo.co.jp+81-9070518560

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026